Portal vein thrombosis and survival in patients with cirrhosis

Michael J. Englesbe, James Kubus, Wajee Muhammad, Christopher J. Sonnenday, Theodore Welling, Jeffrey D. Punch, Raymond J. Lynch, Jorge A. Marrero, Shawn J. Pelletier

Research output: Contribution to journalArticlepeer-review

153 Scopus citations

Abstract

The effects of occlusive portal vein thrombosis (PVT) on the survival of patients with cirrhosis are unknown. This was a retrospective cohort study at a single center. The main exposure variable was the presence of occlusive PVT. The primary outcome measure was time-dependent mortality. A total of 3295 patients were analyzed, and 148 (4.5%) had PVT. Variables independently predictive of mortality from the time of liver transplant evaluation included age [hazard ratio (HR), 1.02; 95% confidence interval (CI), 1.01-1.03], Model for End-Stage Liver Disease (MELD) score (HR, 1.10; 95% CI, 1.08-1.11), hepatitis C (HR, 1.44; 95% CI, 1.24-1.68), and PVT (HR, 2.61; 95% CI, 1.97-3.51). Variables independently associated with the risk of mortality from the time of liver transplant listing included age (HR, 1.02; 95% CI, 1.01-1.03), transplantation (HR, 0.65; 95% CI, 0.50-0.81), MELD (HR, 1.08; 95% CI, 1.06-1.10), hepatitis C (HR, 1.50; 95% CI, 1.18-1.90), and PVT (1.99; 95% CI, 1.25-3.16). The presence of occlusive PVT at the time of liver transplantation was associated with an increased risk of death at 30 days (odds ratio, 7.39; 95% CI, 2.39-22.83). In conclusion, patients with cirrhosis complicated by PVT have an increased risk of death.

Original languageEnglish (US)
Pages (from-to)83-90
Number of pages8
JournalLiver Transplantation
Volume16
Issue number1
DOIs
StatePublished - Jan 2010

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Fingerprint Dive into the research topics of 'Portal vein thrombosis and survival in patients with cirrhosis'. Together they form a unique fingerprint.

Cite this